Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens

25 de octubre de 2014 actualizado por: University of California, San Francisco

Parental Knowledge and Attitudes of Confidential STI Services for Teens

This study will provide new and important information regarding parental knowledge and attitudes of confidential STI and related health care services (prevention, diagnosis and treatment) for teens that may be needed to address the STI epidemic. Using both qualitative and quantitative methods, this study will gather information necessary to develop effective interventions aimed at the often neglected parent component of the teen-parent-health care provider partnership by giving parents knowledge and skills to help them facilitate their adolescent's access to confidential STI services as needed.

Descripción general del estudio

Estado

Terminado

Descripción detallada

Teens' access to confidential services for sexually transmitted infections (STI's) has been assured over time by privacy protections established through statutory and policy routes. Yet, the STI epidemic among youth persists, in part , because many STI's are largely asymptomatic, remain undetected and continue to be transmitted unknowingly. Also, many teens are reluctant to obtain STI services due to embarrassment, fear of disclosure, lack of knowledge about STI diagnosis/treatment, and confidential STI services. How do we bridge the gap between availability and apparent lack of utilization by teens in need of confidential services to prevent STI's and their long term sequelae? One strategy that has been overlooked is the engagement of parents in a partnership with the teen and the provider to effectively guide the developing adolescent towards becoming a responsible and confident adult consumer of health services, especially regarding STI prevention and care including confidential services. Before developing the parental component to a broad-based effort aimed at decreasing the STI rate, especially C. trachomatis, it is important to examine parental knowledge and attitudes towards confidential STI health services for teens and how these might influence parental intention to facilitate their adolescent's accessing appropriate preventive care for STIs. We propose a multi-method research design in 2 phases. Phase 1 comprises a qualitative format (focus groups and 1:1 semi-structured interviews) designed to yield data on parental knowledge and attitudes about confidential STI related health care services for teens. Findings from Phase 1 will then inform Phase 2, a quantitative cross-sectional survey of a random sample of ethnically diverse parents of 12-17 yo teens designed to examine the following questions. First, how does parental knowledge and attitudes about STI confidential care for teens vary according: (a) the adolescent's age and gender; and (b) the specific parental characteristics, e.g., gender, race/ethnicity, insurance status, education, religiosity. Secondly, how does parental knowledge and attitudes about confidential care for teens affect parental behavioral intentions to facilitate their teen's gaining knowledge and skills to be able to access STI preventive confidential services. This research would inform investigations how to strengthen the role of parents and encourage partnerships between health care providers and parents to ultimately improve the health outcomes for teens.

Hypotheses:

  1. Parental knowledge of confidential care for adolescents will increase parental intention to facilitate confidential care
  2. Parental knowledge of STI's will be positively associated with their perceptions of their teen's susceptibility to/ severity of STI
  3. Parental knowledge or suspicion that their adolescent is having sex will be associated with perceptions that their teen is susceptibility to STIs
  4. Parental knowledge of STI's and/or knowledge/ suspicion adolescent is having sex will be associated with parental intention to facilitate confidential care
  5. Perceived susceptibility/severity of their teen to STI will be associated with a greater intention to facilitate confidential care
  6. Perceived benefits of confidential care will be associated with an greater intention to facilitate confidential care
  7. Perceived risks/barriers to confidential care (e.g., logistical/billing; busy practice, no policy/time for provider to see teen alone; perceived increase risky teen behavior due to such sexual health discussions) will be negatively associated with intention to facilitate confidential care
  8. Perceived self-efficacy will be associated with an greater intention to facilitate confidential care
  9. Past behavior/experiences regarding confidential care for parent and/or adolescent will be associated with intention to facilitate confidential care

Specific Aims:

i. To examine parental knowledge and attitudes of confidential health services related to STI care for adolescents

  1. To examine how parental knowledge and attitudes of confidentiality regarding STI and related health care services vary according to parent characteristics
  2. To examine how parental knowledge and attitudes of confidentiality regarding STI and related health care services vary according to child characteristics

ii. To examine how parental knowledge and attitudes toward confidential STI care affects the parent's behavioral intentions to support their adolescent's access to confidential care

iii. To identify key mechanisms that will form the basis of an intervention to improve parent-health care provider partnerships by giving parents knowledge and skills to help them facilitate their adolescent's access to confidential STI services as needed

Tipo de estudio

De observación

Inscripción (Actual)

1216

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • California
      • San Francisco, California, Estados Unidos, 94110
        • Mission Neighborhood Health Center
      • San Francisco, California, Estados Unidos, 94110
        • San Francisco General Hospital
      • San Francisco, California, Estados Unidos, 94115
        • Kaiser Permanente Northern California

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Parents/Guardians who have adolescents between 12-17 years of age

Descripción

Inclusion Criteria:

  • Parents/Guardians who have adolescents between 12-17 years of age

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: Grupo
  • Perspectivas temporales: Transversal

Cohortes e Intervenciones

Grupo / Cohorte
Male Parent/Guardians
Male Parent/Guardian of Adolescent 12-17 yo. Health care members of either San Francisco General Hospital or Kaiser Permanente Northern California.
Female Parent/Guardian
Female Parent/Guardian of Adolescent 12-17 yo. Health care members of either San Francisco General Hospital or Kaiser Permanente Northern California.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Determining parental attitudes regarding confidential health services for their teens
Periodo de tiempo: 4 years
Parental attitudes and knowledge regarding confidential health services will be assessed with focus groups, interviews and phone surveying.
4 years

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Mary-Ann Shafer, MD, University of California, San Francisco

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de septiembre de 2007

Finalización primaria (Actual)

1 de agosto de 2011

Finalización del estudio (Actual)

1 de agosto de 2011

Fechas de registro del estudio

Enviado por primera vez

14 de junio de 2010

Primero enviado que cumplió con los criterios de control de calidad

15 de junio de 2010

Publicado por primera vez (Estimar)

16 de junio de 2010

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

28 de octubre de 2014

Última actualización enviada que cumplió con los criterios de control de calidad

25 de octubre de 2014

Última verificación

1 de octubre de 2014

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir